Thrombosis Prevention Forum 2007

Patient Advocacy and the United States Congress

Geno Merli, MD

Patient Advocacy and the British Parliament

Ajay K. Kakkar, MD

Human Alerts vs. Electronic Alerts

Karen Fiumara, PharmD

Anticoagulation Armamentarium: Update on Drugs and Mechanisms

Sudha Parasuraman, MD

Outpatient Treatment of VTE

Sylvia McKean, MD

Hospital Pharmacists and DVT Prevention During Hospitalization at the Time of Hospital Discharge: a Patient Safety Issue

John Fanikos, RPh, MBA

Implications of an Out-of-Range INR: Bleeding and Clotting Complications

Elaine Hylek, MD

Warfarin Genetics and Dosing: the New Pharmacogenomic Frontier

Samuel Z. Goldhaber, MD

Substituting Generic Drugs for Brand Name Drugs

Jawed Fareed, PhD

Breakout Sessions:

How to Run an Anticoagulation Service (Erin Oliver, PA-C; Mary Kay Kleinschmidt, PA-C; Cheryl Silva, PharmD; Nicole Grasso-Correnti, RN, BSN)

Knowledge is Power: Patient Advocacy (Samuel Z.Goldhaber, MD; Ruth B. Morrison, RN; Tom Hogan; Michael Hefron; Lisa Kory)

VTE Prevention: Making the Evidence Based Guidelines “Come Alive” and Transitioning from Voluntary Adherence to Mandatory Enforcement (Sylvia McKean, MD; John Fanikos, RPh, MBA)

Make a donation through PayPal, it's easy, safe and quick.

NATF • 368 Boylston Street • Brookline, MA 02445 • Phone: (617) 730-4120 • FAX: (617) 738-7652 • Contact Us • Terms of Use
© 2012 North American Thrombosis Forum, Inc.